Latest News about Endo International
Recent news which mentions Endo International
Endo completes $540 million acquisition of BioSpecifics
December 02, 2020
From Business Journals
From Business Journals
From Business Journals
Endo International chooses a familiar face to be new CEO
February 20, 2020
From Business Journals
Endo reaches $8.75M opioid settlement with Oklahoma
January 14, 2020
From Business Journals
Endo begins search for a new CEO
November 05, 2019
From Business Journals
Endo dismisses lawsuit against the FDA after two-year battle
September 30, 2019
From Business Journals
Endo agrees to pay $10M to settle Ohio opioid lawsuits
September 05, 2019
From Business Journals
Endo Stock Surges 17% Following Settlement Agreement
August 20, 2019
From MicroSmallCap
Endo Stock Surges 17% Following Settlement Agreement
August 20, 2019
From MicroSmallCap
FDA ruling on compounding goes Endo's way
March 05, 2019
From Business Journals
FDA files motion to delay Endo litigation, again
February 07, 2019
From Business Journals
Government shutdown puts Endo-FDA lawsuit in limbo
January 02, 2019
From Business Journals
Endo’s Upbeat Earnings: Don’t Get Too Excited
October 30, 2017
From Stocks to Watch
Endo Int’l: New CEO “Has His Work Cut Out For Him”
September 23, 2016
From Stocks to Watch
Endo International Notifies Vivus It Will End Its Commercial Supply And License Agreements Related To Avanafil
December 31, 2015
From Benzinga
Endo International: Uncertain Growth Beyond 2017?
September 01, 2015
From Stocks to Watch
Endo buying generic drug maker for $8B
May 18, 2015
From Business Journals
Salix agrees to Valeant's new offer
March 16, 2015
From Business Journals
Endo starts bidding war for Salix with $11.2B offer
March 11, 2015
From Business Journals
From Benzinga
Tickers
TEVA
From Business Journals
From Business Journals
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.